A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
A Multi-Centre, International, Randomised, Vehicle Controlled, Parallel-Group, Double-Blinded Phase 2 Trial of BB2603 Topical Treatment in Subjects With Distal Subungual Onychomycosis (DSO) of the Toenail
Sponsor: Blueberry Therapeutics
A PHASE2 clinical study on Distal Subungual Onychomycosis and Fungal Infection, this trial is completed. The trial is conducted by Blueberry Therapeutics and has accumulated 14 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Aug 2023 — Sep 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 9 earlier versions
-
Sep 2022 — Aug 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Sep 2021 — Mar 2022 [monthly]
Recruiting PHASE2
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE2
Status: Suspended → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Suspended PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Suspended PHASE2
Status: Not Yet Recruiting → Suspended
-
Feb 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Blueberry Therapeutics
- IQVIA Biotech
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Augsburg, Germany , Berlin, Germany , Bialystok, Poland , Bochum, Germany , Dresden, Germany , Gdansk, Poland , Katowice, Poland , Lodz, Poland , Lublin, Poland , Prague, Czechia and 7 more locations